Japanese | English

| Sitemap |

Investor Relations  |  Environmental and Social Report  |  about Eisai  |  Inquiry

Eisai Global Site Investor Relations Environmental and Social Report about Eisai VITAMIN E Potential Suppliers Inquiry

Understanding Eisai Company Introduction Video Annual Report 2008 Environmental and Social Report 2008			News Release List November 17, 2008 FDA Approves BANZEL™ (rufinamide) as Adjunctive Treatment for Lennox-Gastaut Syndrome November 11, 2008 Eisai Completes Alliance Agreement with TorreyPines Therapeutics for Genetic Research Programs to Discover Genes Associated with LOAD -New Agreement Signed for Eisai to Purchase Research Assets- October 29, 2008 HOUSE OF LORDS REFUSES TO HEAR NICE'S APPEAL
			What's New List November 18, 2008 IR “To Shareholders 97th Interim Report” November 7, 2008 Social Activities “Eisai Kawashima Industrial Complex Wins Minister of Health, Labour and Welfare's Prize for promoting Reduce, Reuse and Recycle” November 4, 2008 Correction of the English Reference Data
			Information MORPHOTEK®, INC. AND PIVOTAL BIOSCIENCES ANNOUNCE AGREEMENT FOR THE DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODIES(September 26, 2008) Corporate Governance Report updated (July 31, 2008) Notice of Resolutions at the 96th Ordinary General Meeting of Shareholders (June 20, 2008)

Privacy Policy  |  Terms of Use  |  Accessibility